These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 9893190)

  • 1. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ; Dempsey OJ; Aziz I
    Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.
    Aziz I; Lipworth BJ
    Chest; 1999 Mar; 115(3):623-8. PubMed ID: 10084466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
    Lipworth BJ
    Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative trough effects of formoterol and salmeterol on lymphocyte beta2-adrenoceptor--regulation and bronchodilatation.
    Aziz I; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1999 Aug; 55(6):431-6. PubMed ID: 10492055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
    Nightingale JA; Rogers DF; Barnes PJ
    Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.
    van der Woude HJ; Aalbers R
    Eur Respir J; 2001 Aug; 18(2):269-71. PubMed ID: 11529283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.
    Lee DK; Currie GP; Hall IP; Lima JJ; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jan; 57(1):68-75. PubMed ID: 14678342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists.
    van Veen A; Weller FR; Wierenga EA; Jansen HM; Jonkers RE
    Pulm Pharmacol Ther; 2003; 16(3):153-61. PubMed ID: 12749831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction.
    Politiek MJ; Boorsma M; Aalbers R
    Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
    Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
    Richter K; Janicki S; Jörres RA; Magnussen H
    Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.
    Lipworth BJ; Aziz I
    Chest; 2000 Jan; 117(1):156-62. PubMed ID: 10631214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.